Skip to content

Clinical trials

Completed Alzheimer Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: South Korea Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062
20074
200810
20094
20104
20115
20124
20134
201410
20152
20166
20174
20182
20194
20202
20211
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Korea Inc.6
GlaxoSmithKline6
Seoul National University Hospital6
Pfizer4
H. Lundbeck A/S3
Hoffmann-La Roche3
Icure Pharmaceutical Inc.3
Medipost Co Ltd.3
Samsung Medical Center3
Asan Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease76
Cognitive Dysfunction9
Dementia9
Neurodegenerative Diseases3
Tauopathies3
Disease2
Lymphoma, Follicular2
Nerve Degeneration2
Pick Disease of the Brain2
Amyloid Neuropathies, Familial1

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.